Biotech
The pace of innovation for patents in the technology fields of energy transition and decarbonisation has increased sharply in recent years. Our recent analysis of […]
Read moreBiotech
The pace of innovation in seafood and aquatic food products has increased dramatically in recent years. A recent analysis of the global patent landscape conducted […]
Read moreBiotech
Considerations from an IP perspective During the development of a branded product, the aspirations for its use are often large and always hold great potential. […]
Read moreBiotech
After decades of discussion, the so-called “Unitary Patent System”, i.e. the establishment of a Unitary Patent (UP) and a Unified Patent Court (UPC), entered into […]
Read moreBiotech
The Legal Board of Appeal (LBoA) of the European Patent Office (EPO) concluded in the recent decision J5/23 that „signature“ within Article 72 of the […]
Read moreBiotech
Videos and presentations Richard Hung (MORRISON & FOERSTER): Why bother with IP litigation in the US? US IP litigation is from a European perspective perceived […]
Read moreBiotech
Willem Hoyng: The wolf IS coming – future IP litigation under the UPC What will change strategically when the UPC enters into force in the […]
Read more